Mechanisms of organophosphate neurotoxicity

Yi-Hua Tsai1, Pamela J Lein1

  • 1Department of Molecular Sciences, University of California, Davis School of Veterinary Medicine, 1089 Veterinary Medicine Drive, Davis, CA, 95616, USA.

Insights

Organophosphate (OP) neurotoxicity involves more than just acetylcholinesterase (AChE) inhibition. Research explores noncholinergic mechanisms contributing to acute and chronic OP poisoning effects.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Organophosphate (OP) compounds are widely used pesticides and chemical warfare agents.
  • The primary known mechanism of OP neurotoxicity is the inhibition of acetylcholinesterase (AChE), an enzyme crucial for nerve function.
  • Emerging evidence suggests noncholinergic pathways also contribute significantly to OP-induced neurotoxicity.

Purpose of the Study:

  • To review recent studies on the mechanistic insights into OP neurotoxicity.
  • To elucidate the roles of AChE inhibition versus noncholinergic mechanisms in OP-induced neurotoxic effects.
  • To highlight data gaps and challenges in understanding OP neurotoxicity.

Main Methods:

  • Literature review of recently published studies.
  • Analysis of mechanistic insights into OP neurotoxicity.
  • Synthesis of findings related to OP-induced status epilepticus, long-term consequences, and repeated low-level exposures.

Main Results:

  • OPs can induce status epilepticus through mechanisms beyond AChE inhibition.
  • Acute OP exposure can lead to long-term neurological deficits.
  • Repeated low-level OP exposures exhibit distinct neurotoxic effects.

Conclusions:

  • AChE inhibition is not the sole determinant of OP neurotoxicity.
  • Noncholinergic mechanisms are critical for understanding the full spectrum of OP neurotoxic effects.
  • Further research is needed to address key data gaps for improved diagnostics and therapeutics.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.2K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.1K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
725
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.0K